CD38 expression assessed on 37 AML and 12 T-ALL patients highlighted that CD38 expression is heterogenous in AML, more uniform in T-ALL, and that expression did not correlate with progressive disease [81]. Here, CD38 is linked to acute myeloid leukemia.